These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1317147)

  • 1. In vitro drug combination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil with anti-human immunodeficiency virus or anticancer nucleosides.
    Machida H; Ashida N; Ikeda T; Sakata S; Baba M; Shigeta S
    Antimicrob Agents Chemother; 1992 Jan; 36(1):214-6. PubMed ID: 1317147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Sakuma T
    Antimicrob Agents Chemother; 1984 Jun; 25(6):742-6. PubMed ID: 6331298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against thymidine kinase negative strains of varicella-zoster virus.
    Kawai H; Yoshida I; Suzutani T
    Microbiol Immunol; 1993; 37(11):877-82. PubMed ID: 8295566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral potencies of BV-araU and related nucleoside analogues against varicella-zoster virus in different cell lines.
    Machida H; Ijichi K; Ohta A; Honda M; Niimura M
    Microbiol Immunol; 1990; 34(11):959-65. PubMed ID: 1965323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral bioavailability and anti-simian varicella virus efficacy of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in monkeys.
    Soike K; Huang JL; Tu JI; Stouffer B; Mitroka JG; Swerdel M; Olsen S; Bonner DP; Tuomari AV; Field AK
    J Infect Dis; 1992 Apr; 165(4):732-6. PubMed ID: 1313071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two bromovinyl nucleoside analogs, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and E-5-(2-bromovinyl)-2'-deoxyuridine, with acyclovir in inhibition of Epstein-Barr virus replication.
    Lin JC; Machida H
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1068-72. PubMed ID: 2847639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds.
    Machida H; Sakata S
    Antiviral Res; 1984 Jun; 4(3):135-41. PubMed ID: 6089657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of various nucleosides on antiviral activity and metabolism of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil against herpes simplex virus types 1 and 2.
    Suzutani T; Machida H; Sakuma T; Azuma M
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1547-51. PubMed ID: 2847634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manual and automated determination of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil and its metabolite (E)-5-(2-bromovinyl)uracil in urine.
    Whigan DB; Schuster AE
    J Chromatogr B Biomed Appl; 1995 Feb; 664(2):357-63. PubMed ID: 7780588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of BV-araU and acyclovir on varicella-zoster virus replication with various length and timing of drug exposure.
    Machida H; Nishitani M; Ashida N
    Microbiol Immunol; 1994; 38(2):109-15. PubMed ID: 8041297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different antiviral potencies of BV-araU and related nucleoside analogues against herpes simplex virus type 1 in human cell lines and Vero cells.
    Machida H; Nishitani M; Suzutani T; Hayashi K
    Microbiol Immunol; 1991; 35(11):963-73. PubMed ID: 1663576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic fate of [3H]1-beta-D-arabinofuranosyl-5-[(E)-2-bromovinyl]uracil in herpes simplex virus type 1-infected cells.
    Ashida N; Sakata S; Machida H
    Microbiol Immunol; 1997; 41(12):957-64. PubMed ID: 9492181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal toxicity and ocular kinetics of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in rabbits.
    Mochizuki K; Torisaki M; Yamashita Y; Komatsu M; Tanahashi T; Ijichi K; Machida H
    Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):503-8. PubMed ID: 7926887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of DNA synthesis by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Suzutani T; Machida H; Honess RW
    Microbiol Immunol; 1993; 37(6):511-3. PubMed ID: 8231965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship between (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BV-araU, V-araU) in inhibition of Epstein-Barr virus replication.
    Lin JC; Reefschläger J; Herrmann G; Pagano JS
    Antiviral Res; 1992 Jan; 17(1):43-52. PubMed ID: 1310582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deglycosylation of antiherpesviral 5-substituted arabinosyluracil derivatives by rat liver extract and enterobacteria cells.
    Machida H; Watanabe Y; Kano F; Sakata S; Kumagai M; Yamaguchi T
    Biochem Pharmacol; 1995 Mar; 49(6):763-6. PubMed ID: 7702634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
    Balzarini J; Sienaert R; Liekens S; Van Kuilenburg A; Carangio A; Esnouf R; De Clercq E; McGuigan C
    Mol Pharmacol; 2002 May; 61(5):1140-5. PubMed ID: 11961132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses.
    Choi Y; Li L; Grill S; Gullen E; Lee CS; Gumina G; Tsujii E; Cheng YC; Chu CK
    J Med Chem; 2000 Jun; 43(13):2538-46. PubMed ID: 10891113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of 5'-ether prodrugs of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in rats.
    Ashida N; Ijichi K; Watanabe Y; Machida H
    Biochem Pharmacol; 1993 Dec; 46(12):2201-7. PubMed ID: 8274153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.